Improving the development of insulin-producing cells from stem cells
Modulating heterochromatin to improve beta cell differentiation from stem cells
This study is looking at ways to help grow more insulin-producing cells from human stem cells to better support people with Type 1 diabetes, so they might have better treatment options beyond just insulin shots.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10849841 on NIH RePORTER |
What this research studies
This research focuses on enhancing the differentiation of pancreatic beta cells from human embryonic stem cells by modulating specific gene silencing mechanisms. It aims to address the challenges faced by patients with Type 1 diabetes, who suffer from a lack of insulin-producing cells due to autoimmune destruction. By understanding and manipulating the cellular processes involved in beta cell maturation, the research seeks to create more effective and reliable sources of insulin-producing cells for transplantation. This could potentially lead to improved treatments for diabetes patients who currently rely on insulin injections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with Type 1 diabetes who are seeking innovative treatment options.
Not a fit: Patients with Type 2 diabetes or those who do not have a need for beta cell replacement therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new source of insulin-producing cells for patients with Type 1 diabetes, reducing their dependence on insulin therapy.
How similar studies have performed: Previous research has shown promise in generating insulin-producing cells from stem cells, but this approach aims to refine and improve the efficiency of that process.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Zaret, Kenneth — University of Pennsylvania
- Study coordinator: Zaret, Kenneth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.